Mary’s was the first to offer transdermal patches. Mary’s pioneered the intersection of plant and science. And Mary’s was first to market THCa and CBN and discovered harvesting techniques for the isolation of CBC.
Their founders are among some of the first in the cannabis industry to truly maximize the benefits of cannabinoids, terpenes and other plant nutrients. And they continue to develop new cutting-edge approaches for isolating, manufacturing and marketing cannabis.
The concept of bioavailability is the cornerstone to understanding the benefits of Mary’s Medicinals. Bioavailability is the proportion of a drug or other substance which enters the circulation when introduced into the body, and then has an active effect. Mary’s team of chemists work hard to scientifically formulate cannabis products with high bioavailability, or absorption, based off the knowledge we have from traditional pharmaceutical products.
High bioavailabilty products allow for the ability to use less cannabis to reach desired effect, which is imperative for tolerance and budget management.
Mary’s provides their patients with a better quality of life through plant-based ingredients and innovations. Merging modern technology with established horticulture practices allows for the easy integration of the therapeutic power of cannabis into one’s daily routine.